Bulletproof 360, Inc. Issues Allergy Alert on Undeclared Milk in Collagen Protein Dietary Supplement
For Immediate Release
January 25, 2018
Contact
Consumers
Customer Support
20support@bulletproof.com"> support@bulletproof.com
(877) 651-9482
Announcement
Out of an abundance of caution, Bulletproof 360, Inc. is voluntarily recalling one lot #1017088 of Bulletproof Collagen Protein dietary supplement due to undeclared milk. People who have an allergy or severe sensitivity to milk run the risk of serious or life-threatening allergic reaction if they consume this product.
The recalled product is Bulletproof Collagen Protein dietary supplement, packaged in a 16-oz. composite-film bag and has the UPC 8 15709 02115 3. The affected lot #1017088 EXP03/19 is found on the back panel of a bag, and EXP03/19 means expires by March 2019. All other lots of Bulletproof Collagen Protein and other products purchased at bulletproof.com are not affected by this recall.
Affected Bulletproof Collagen Protein was sold directly to distributors in CA, CO, CT, FL, GA, IA, IN, NH, NY, OR, PA, SC, TX, WA, WI and product has been further distributed to retail stores nationwide.
This voluntary recall was initiated after we discovered that bulk whey (milk) protein was mis-labeled as collagen protein by our third-party manufacturer during the manufacturing process. As a result, the affected Bulletproof Collagen Protein product contains the whey (milk) protein and the finished product label does not declare milk.
Thisrecall is being made with the knowledge of the U.S. Food and Drug Administration.
Consumers who have purchased the affected product (lot # 1017088) and have an allergy or severe sensitivity to milk are urged not to consume it and should return product to the original location of the purchase for a full refund.
Consumers with questions related to the recall can contact our Customer Support Team at: support@bulletproof.com or reach out to us via phone at: (877) 651-9482, Monday through Friday, 8:00 am - 5:00 pm Pacific Standard Time.
###
Comments (0)